The Editors invite investigators to submit short communications of potential interest to the readers of the Journal for this new department which begins in the current issue.They may cover any aspect of the subject matter of diabetes: clinical notes, observations on therapeutic agents, sociomedical problems, or unusual clinical experiences.Communications should not exceed 1,000 words except in unusual circumstances. Figures and tables should be limited to one of each, and references should be ten to twenty in number.These communications should not be used to establish priority of observation for work in progress, or for work that is intended for publication in extenso, within the near future.If this department proves useful by attracting well-written, short papers dealing with findings of interest to most of our readers, it will become a regular feature. Its success will depend upon the quality of the contributions offered.
SUMMARYThe effect of sulfonylurea compounds on the plasma triglycerides was tested in eighteen adult diabetics. Sulfonylurea caused a mean reduction in plasma triglyceride of 19 mg. per cent. The magnitude of the reduction did not correlate with the hypoglycemic effect. The reduction in triglyceride was apparent in spite of weight gain in some subjects.
Little is known about costs of waiting for orthopaedic outpatient specialist consultations. A subset of papers on costs of waiting was identified from the body of literature identified in a systematic scoping review registered with Prospero (registration CRD42016047332), with the aim of exploring the impact of waiting for orthopaedic outpatient specialist consultations. Medline, Embase, Pubmed, and NHS Economic evaluation database (NHS-EED) were searched from inception until February 2018. The systematic scoping search yielded 139 articles, of which four reported specifically on costs (papers published 2002, 2005, 2009, 2012). All papers reported on hip and/or knee complaints. Cost data was extracted, described and standardised as Australian dollars (AUD$). This review identified limited, non-current evidence on economic costs of waiting for outpatient orthopaedic surgical consultations. Whilst heterogeneous cost items, timing of collection, and dispersion measures constrained synthesis, it appears that direct and indirect costs of waiting may be significant to patients and health systems. Pharmaceuticals were the most common cost (from $263-$1,912). Future research into costs of waiting for orthopaedic conditions should report standardised cost measures, taken at standard time periods throughout the waiting period.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.